Fusobacterium nucleatum and colorectal cancer: A mechanistic overview

Colorectal cancer (CRC) is the third most prevalent cancer in the world. There are many risk factors involved in CRC. According to recent findings, the tumor microenvironment and feces samples of patients with CRC are enriched by Fusobacterium nucleatum. Thus, F. nucleatum is proposed as one of the risk factors in the initiation and progression of CRC. The most important mechanisms of Fusobacterium nucleatum involved in CRC carcinogenesis are immune modulation (such as increasing myeloid-derived suppressor cells and inhibitory receptors of natural killer cells), virulence factors (such as FadA and Fap2), microRNAs (such as miR-21), and bacteria metabolism. The aim of this review was to evaluate the mechanisms underlying the action of F. nucleatum in CRC.     

Advanced therapeutic modalities in hepatocellular carcinoma: Novel insights

Hepatocellular carcinoma (HCC), the most common type of liver cancer, is usually a latent and asymptomatic malignancy caused by different aetiologies, which is a result of various aberrant molecular heterogeneity and often diagnosed at advanced stages. The incidence and prevalence have significantly increased because of sedentary lifestyle, diabetes, chronic infection with hepatotropic viruses and exposure to aflatoxins. Due to advanced intra- or extrahepatic metastasis, recurrence is very common even after radical resection. In this paper, we highlighted novel therapeutic modalities, such as molecular-targeted therapies, targeted radionuclide therapies and epigenetic modification-based therapies. These topics are trending headlines and their combination with cell-based immunotherapies, and gene therapy has provided promising prospects for the future of HCC treatment. Moreover, a comprehensive overview of current and advanced therapeutic approaches is discussed and the advantages and limitations of each strategy are described. Finally, very recent and approved novel combined therapies and their promising results in HCC treatment have been introduced.     

Morpho–physiological responses of Rocket (<Emphasis Type="Italic">Eruca sativa</Emphasis> L.) varieties to sodium sulfate (Na<Subscript>2</Subscript>SO<Subscript>4</Subscript>) stress: an experimental approach

Rocket (Eruca sativa L.) is a medicinal plant that belongs to the Brassicaceae family and was reported to be a tolerant plant under soil salinity as well as high genetic diversity among its varieties. Since morphological and physiological changes to sodium sulfate stress toward this plant have not been investigated yet, the present study was implemented to assess the response of rocket (Eruca sativa L.) varieties to sodium sulfate (Na2SO4) stress as well as the relationship among these traits. Two varieties of rocket plants, the Iranian and Italian ones, were subjected to four salinity (Na₂SO₄) treatments [0 (control), 15, 30 and 60 mM of Na₂SO₄ solution] and three growth stages (49, 65, and 74 days) in factorial experiment with completely randomized design and three replications were considered. Some morphologic traits such as grain yield were measured during the growth period. The results of the analysis of variances between the mentioned variables indicated a significant difference between the varieties in terms of K⁺, Na⁺, Na⁺/K⁺, leaf length, grain yield, organic and mineral matter. The results of correlation and regression of the amounts of K⁺ showed a linear relationship with the grain yield and its variations were not independent from the variations of grain yield. Eventually, it seems that the Italian variety was more tolerant and having better performance in comparison with the Iranian variety, in response to salt stress.     

The first confirmed records of Omani Owl,Strix butleri (A. O. Hume, 1878) (Aves: Strigidae), from Iran

Although the Omani Owl Strix butleri (A. O. Hume, 1878) was previously reported from southern Iran, this note details the first confirmed records of this species from Mashhad (Khorasan) and Jam (Bushehr) in 2015, after recent revision of the taxonomy of this species in the Middle East.     

A comparison of H-reflex in the triceps surae muscle group in patients with S1 radiculopathy

Despite differences in the anatomical and physiological characteristics of the medial gastrocnemius (MG), lateral gastrocnemius (LG), and soleus (Sol) muscles, it is common practice to investigate them as single triceps surae H-reflex recordings. The aim of this study was to compare the latencies of H-reflex recordings from the Sol, MG, and LG in patients with explicit magnetic resonance imaging (MRI) evidence of unilateral S1 radiculopathy and also compare their diagnostic yield in varied clinical characteristics (i.e., symptom duration and severity of involvement). We found a significant difference between H-reflex latencies of Sol and the two others (p?相似文献   

GPR30 contributes to estrogen-induced thymic atrophy

The mechanisms by which prolonged estrogen exposures, such as estrogen therapy and pregnancy, reduce thymus weight, cellularity, and CD4 and CD8 phenotype expression, have not been well defined. In this study, the roles played by the membrane estrogen receptor, G protein-coupled receptor 30 (GPR30), and the intracellular estrogen receptors, estrogen receptor alpha (ERalpha) and beta (ERbeta), in 17beta-estradiol (E2)-induced thymic atrophy were distinguished by construction and the side-by-side comparison of GPR30-deficient mice with ERalpha and ERbeta gene-deficient mice. Our study shows that whereas ERalpha mediated exclusively the early developmental blockage of thymocytes, GPR30 was indispensable for thymocyte apoptosis that preferentially occurs in T cell receptor beta chain(-/low) double-positive thymocytes. Additionally, G1, a specific GPR30 agonist, induces thymic atrophy and thymocyte apoptosis, but not developmental blockage. Finally, E2 treatment attenuates the activation of nuclear factor-kappa B in CD25(-)CD4(-)CD8(-) double-negative thymocytes through an ERalpha-dependent yet ERbeta- and GPR30-independent pathway. Differential inhibition of nuclear factor-kappaB by ERalpha and GPR30 might underlie their disparate physiological effects on thymocytes. Our study distinguishes, for the first time, the respective contributions of nuclear and membrane E2 receptors in negative regulation of thymic development.